期刊文献+

抗凋亡融合蛋白PTD-Bcl-xL原核表达载体的构建及表达纯化 被引量:1

Prokaryotic Expression Plasmid Construction and Expression/Purification of Anti-apoptotic Fusion Protein PTD-Bcl-xL
下载PDF
导出
摘要 人工抗凋亡蛋白PTD-Bcl-x L能保护多种因素引起的细胞异常凋亡,为了获得高纯度Bcl-x L与PTD(Protein transduction domains)的融合蛋白,首先采用TRIzol法提取SD大鼠肝脏总RNA,将RNA反转录为c DNA,设计引物以c DNA为模板,PCR扩增Bcl-x L基因,构建p UM19-T-Bcl-x L质粒,并对质粒双酶切鉴定和测序鉴定;其次设计包含PTD序列的Bcl-x L引物,以测序正确的p UM19-T-Bcl-x L质粒为模板,PCR扩增PTD-Bcl-x L序列,将扩增序列克隆入p ET28a载体,构建PTD-Bcl-x L蛋白的原核表达质粒p ET28a-PTD-Bcl-x L,并对p ET28a-PTD-Bcl-x L载体双酶切鉴定和测序鉴定;将p ET28a-PTD-Bcl-x L重组质粒转化大肠杆菌BL21(DE3),用IPTG诱导表达,并对IPTG诱导融合蛋白表达的浓度和诱导时间进行了优化;SDS-PAGE分析表达蛋白的可溶性情况,在变性条件下用Ni-NTA琼脂纯化融合蛋白;最后用SDS-PAGE、Western Blot及质谱对融合蛋白进行鉴定。结果表明:双酶切p UM19-T-Bcl-x L质粒出现约774 bp大小条带,p UM19-T-Bcl-x L质粒测序结果与NCBI数据库比对序列一致,表明成功构建p UM19-T-Bcl-x L质粒;双酶切p ET28a-PTD-Bcl-x L质粒出现约744 bp大小条带,p ET28a-PTD-Bcl-x L质粒测序结果与预期序列一致,表明成功构建了p ET28a-PTD-Bcl-x L原核表达载体;在IPTG诱导下p ET28a-Bcl-x L重组质粒在大肠杆菌BL21(DE3)中表达出36 k Da大小蛋白,最优IPTG诱导浓度为0.1 mmol/L,最佳IPTG诱导时间为6 h;SDS-PAGE电泳显示融合蛋白主要出现在菌液超声后的沉淀里,以包涵体形式表达,经Ni-NTA琼脂纯化获得了高纯度的融合蛋白;Western Blot和质谱鉴定证明IPTG诱导表达蛋白和纯化的融合蛋白为PTD-Bcl-x L蛋白。纯化得到了PTD-Bc L-x L融合蛋白,推进了PTD-Bcl-x L蛋白在猪、牛等家畜精液冷冻保存的应用进程。 Artificial anti-apoptotic protein PTD-Bcl-x L can control abnormal apoptosis induced by a variety of factors. The present study was to obtain a high-purity Bcl-x L and PTD( Protein transduction domains) fusion protein. SD rat liver total RNA was extracted by TRIzol and transcribed into c DNA. Bcl-x L gene was amplified by PCR with c DNA as a template and was cloned into p UM19-T vector to construct p UM19-T-Bcl-x L plasmid,which was Identified by restriction enzyme digestion and sequencing and the p UM19-T-Bcl-x L plasmid was used as a template to amplify PTD-Bcl-x L fragment which was cloned into vector p ET28 a to construct recombinant plasmid p ET28aPTD-Bcl-x L and PTD sequence were designed to be placed before the Bcl-x L by designing primers. Then the recombinant plasmid was identified by restriction enzyme and was transformed into E. coli BL21( DE3),PTD-Bcl-x L fu-sion protein was induced to express with different IPTG concentration and induction time. Then the expression culture was analyzed for it's solubility and was prepared to purify PTD-Bcl-x L fusion protein with Ni-NTA agarose under denaturing condition. Finally,the expressing culture and purified protein was identified with SDS-PAGE analysis,Western Blot and MS. The results showed that detected by sequencing and enzyme digestion plasmid p UM19-TBcl-x L was constructed; prokaryotic expression vector p ET28a-PTD-Bcl-x L was constructed with confirmed by sequencing and enzyme digestion; The fused protein PTD-Bcl-x L could be expressed by IPTG induction with 0. 1mmol / L IPTG induction 6 hours for well expression; The fusion protein expressed in an insoluble form of inclusion bodies and a high-purity fused protein was obtained with Ni-NTA agarose purification; the expressing culture and purified protein were proved to be the PTD-Bcl-x L fusion protein with SDS-PAGE,Western Blot and MS analysis.This study obtains purified PTD-Bc L-x L fusion protein and promotes the application process PTD-Bcl-x L protein in pork,beef and other livestock semen cryopreservation.
出处 《华北农学报》 CSCD 北大核心 2016年第1期1-7,共7页 Acta Agriculturae Boreali-Sinica
基金 广西科学研究与技术开发计划项目(桂科能1598022-2) 广西畜禽品种改良站横向科技项目(20140220)
关键词 BCL-X L蛋白 PTD 原核表达 蛋白纯化 Bcl-xL protein PTD Prokaryotic expression Protein purification
  • 相关文献

参考文献24

  • 1Harb J G, Neviani P, Chyla B J, et al. Bcl-xL anti-apoptot- ic network is dispensable for development and mainte-nance of CML but is required for disease progression where it represents a new therapeutic target [ J]. Leuke- mia,2013,27 (10) : 1996 - 2005.
  • 2Edlich F, Banerjee S, Suzuki M, et al. Bcl-x (L) retro- translocates Bax from the mitochondria into the cytosol [ J]. Cell ,2011,145(1) :104 - 116.
  • 3Maiuri M C, Le Toumelin G, Criollo A, et al. Functional and physical interaction between Bcl-X (L) and a BH3- like domain in Beelin-1 [ J ]. The EMBO Journal,2007, 26(10) :2527 - 2539.
  • 4Avery S,Hirst A J, Baker D, et al. BCL-XL mediates the strong selective advantage of a 20q11. 21 amplification commonly found in human embryonic stem cell cultures [J]. Stem Cell Reports,2013,1(5) :379 -386.
  • 5Jonas E A. Contributions of Bcl-xL to acute and long term changes in bioenergeties during neuronal plasticity [ J]. Biochimiea et Biophysiea Aeta, 2014,1842 ( 8 ) : 1168 - 1178.
  • 6Andrade D M, Scherer S W, Minassian B A. Protein thera- py for Unverrieht-Lundborg disease using eystatin B trans- duction by TAT-PTD. Is it that simple? [ J]. Epilepsy Research ,2006,72 ( 1 ) :75 - 79.
  • 7Schwarze S R, Ho A, Vocero-Akbani A, et al. In vivo pro- tein transduction:Delivery of a biologically active protein into the mouse [ J]. Science, 1999,285 ( 5433 ) : 1569 - 1572.
  • 8Asoh S, Mori T, Nagai S, et al. Zonal necrosis prevented by transduction of the artificial anti-death FNK protein [ J ]. Cell Death and Differentiation,2005,12 ( 4 ) : 384 - 394.
  • 9Hasbimoto M, Taniguchi M, Yoshino S, et al. S Phase- preferential Cre-recombination in mammalian cells re- vealed by HIV-TAT-PTD-mediated protein transduction [ J ]. Journal of Biochemistry,2008,143 ( 1 ) :87 - 95.
  • 10Mie M, Mori K,Funabashi H, et al. Delivery of antibody- captured proteins into living cells using PTD-fused protein A [ J ]. Biotechnology Letters, 2006, 28 ( 15 ) : 1209 - 1214.

二级参考文献61

共引文献29

同被引文献1

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部